NovelStem International (NSTM) Other Accumulated Expenses (2021 - 2026)
NovelStem International (NSTM) posted Other Accumulated Expenses of $177,758 for Q2 2026, up 119.0% from $81,166 a year earlier and up 16.0% from the prior quarter.
Powered by 
Analysis
NovelStem International (NSTM) Other Accumulated Expenses (2021 - 2026) Analysis & Trends
At the end of FY2025, NovelStem International's Other Accumulated Expenses came in at $129,208, down 8.0% from FY2024.
- Annual Other Accumulated Expenses shows a four-year compound annual growth rate of 6.6% (FY2021 to FY2025).
- In prior years, NovelStem International's Other Accumulated Expenses was $140,429 in FY2024 (+222.2%), $43,588 in FY2023 (+415.8%), $8,450 in FY2022 (-91.6%) and $100,000 in FY2021.
- The Q2 2026 figure stands as the highest quarterly Other Accumulated Expenses since Q1 2025.
- On a year-over-year basis, Other Accumulated Expenses increased in four of the last six quarters, with growth averaging 91.5%.
- The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q4 2023, with growth of 415.8%; the weakest was Q4 2022, with a decline of 91.6%.
- According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $153,181 (Q1 2026), $129,208 (Q4 2025) and $105,824 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | NovelStem International | 493,324.54 | 346,279.54 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 177,758.00 |
| Mar 31, 2026 | 153,181.00 |
| Dec 31, 2025 | 129,208.00 |
| Sep 30, 2025 | 105,824.00 |
| Jun 30, 2025 | 81,166.00 |
| Mar 31, 2025 | 177,829.00 |
| Dec 31, 2024 | 140,429.00 |
| Sep 30, 2024 | 103,739.00 |
| Mar 31, 2024 | 54,314.00 |
| Dec 31, 2023 | 43,588.00 |
| Sep 30, 2023 | 33,506.00 |
| Jun 30, 2023 | 24,298.00 |
| Dec 31, 2022 | 8,450.00 |
| Dec 31, 2021 | 100,000.00 |
API Access
NovelStem International Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=NSTM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "NSTM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=NSTM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();